NASDAQ:GNCA Genocea Biosciences (GNCA) Stock Price, News & Analysis → At first glance, this chart looks like nonsense… (From The TradingPub) (Ad) Free GNCA Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume3,000 shsAverage Volume83,499 shsMarket Capitalization$6,000.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial Media Get Genocea Biosciences alerts: Email Address Ad Crypto Swap ProfitsHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here About Genocea Biosciences Stock (NASDAQ:GNCA)Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products include GEN-011, an adoptive T cell therapy, which is in Phase 1/2a clinical trials for the treatment of solid tumors; and GEN-009, a neoantigen vaccine candidate, which is in Phase 1/2a clinical trials that delivers adjuvanted synthetic long peptides spanning ATLAS-identified anti-tumor neoantigens. The company was incorporated in 2006 and is based in Cambridge, Massachusetts. On July 5, 2022, Genocea Biosciences, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Massachusetts.Read More Ad Crypto Swap ProfitsHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here GNCA Stock News HeadlinesApril 24, 2024 | americanbankingnews.comGenocea Biosciences (NASDAQ:GNCA) Now Covered by StockNews.comApril 24, 2024 | americanbankingnews.comReviewing Genocea Biosciences (NASDAQ:GNCA) and Scilex (NASDAQ:SCLX)April 25, 2024 | WealthPress (Ad)$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…April 16, 2024 | americanbankingnews.comGenocea Biosciences (NASDAQ:GNCA) Now Covered by Analysts at StockNews.comJanuary 5, 2024 | morningstar.comGenocea Biosciences Inc GNCAQJanuary 27, 2023 | seekingalpha.comGNCAQ Genocea Biosciences, Inc.August 31, 2022 | thestreet.com3 Health Care Stocks Under $10 to Trade for BreakoutsAugust 9, 2022 | uk.finance.yahoo.comGenocea Biosciences, Inc. (GNCA)April 25, 2024 | Crypto Swap Profits (Ad)He Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.May 27, 2022 | seekingalpha.comGRPN, GNCA and LAB among mid-day moversMay 25, 2022 | finance.yahoo.comGenocea Biosciences to shut downMay 24, 2022 | finance.yahoo.comGenocea Closes Shop, Delists From NASDAQMay 24, 2022 | finance.yahoo.comThree weeks after layoffs, Genocea shuts down entirelyMay 24, 2022 | seekingalpha.comGenocea stock crashes 64% on winding down of operations, Nasdaq delistingMay 24, 2022 | finance.yahoo.comGenocea Announces Wind Down of Operations and Delisting From NASDAQMay 2, 2022 | finance.yahoo.comGenocea cuts two-thirds of staff, explores a saleApril 29, 2022 | seekingalpha.comGenocea stock plunges on cutting workforce by 65% and exploring sale or merger alternatives; Stifel cuts PT to $0.16April 28, 2022 | finance.yahoo.comGenocea Initiates Restructuring and Announces Plan to Explore Strategic AlternativesApril 11, 2022 | finance.yahoo.comImplied Volatility Surging for Genocea (GNCA) Stock OptionsApril 8, 2022 | uk.investing.comGenocea Biosciences Stock Dives After Early Data From GEN-011 Trial In Pretreated Solid Tumor PatientsApril 8, 2022 | finance.yahoo.comGenocea Presents Encouraging Initial Data from GEN-011 Phase 1/2a Trial at AACR 2022April 4, 2022 | finance.yahoo.comGenocea Biosciences to Host Investor WebinarMarch 14, 2022 | finance.yahoo.comGenocea to Present at the 32nd Annual Oppenheimer Healthcare ConferenceMarch 10, 2022 | seekingalpha.comGenocea Biosciences GAAP EPS of -$0.19 misses by $0.01March 10, 2022 | apnews.comGenocea Biosciences: Q4 Earnings SnapshotMarch 10, 2022 | finance.yahoo.comGenocea Provides Fourth Quarter 2021 Corporate UpdateMarch 9, 2022 | seekingalpha.comGenocea Biosciences Q4 2021 Earnings PreviewSee More Headlines Receive GNCA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genocea Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings10/27/2021Today4/24/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:GNCA CUSIPN/A CIK1457612 Webwww.genocea.com Phone(617) 876-8191Fax617-876-8192Employees74Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.61) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-33,200,000.00 Net MarginsN/A Pretax Margin-1,946.15% Return on Equity-182.88% Return on Assets-62.76% Debt Debt-to-Equity Ratio0.24 Current Ratio1.35 Quick Ratio1.35 Sales & Book Value Annual Sales$1.91 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$0.47 per share Price / BookN/AMiscellaneous Outstanding Shares58,730,000Free Float57,788,000Market Cap$6,000.00 OptionableNot Optionable Beta1.61 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. William D. Clark M.B.A. (Age 53)Pres, CEO & Director Comp: $837.42kDr. Jessica Baker Flechtner Ph.D. (Age 50)Chief Scientific Officer Comp: $585.18kMs. Diantha Duvall CPA (Age 50)M.B.A., CFO & Sec. Key CompetitorsHTG Molecular DiagnosticsNASDAQ:HTGMQKaleido BiosciencesNASDAQ:KLDOViveve MedicalNASDAQ:VIVEAllied Healthcare ProductsNASDAQ:AHPINovanNASDAQ:NOVNView All Competitors GNCA Stock Analysis - Frequently Asked Questions How were Genocea Biosciences' earnings last quarter? Genocea Biosciences, Inc. (NASDAQ:GNCA) posted its earnings results on Wednesday, October, 27th. The biotechnology company reported ($0.05) earnings per share for the quarter, topping analysts' consensus estimates of ($0.20) by $0.15. The biotechnology company had revenue of $1.64 million for the quarter. During the same period in the prior year, the company posted ($0.26) EPS. What is William Clark's approval rating as Genocea Biosciences' CEO? 5 employees have rated Genocea Biosciences Chief Executive Officer William Clark on Glassdoor.com. William Clark has an approval rating of 82% among the company's employees. What other stocks do shareholders of Genocea Biosciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Genocea Biosciences investors own include Hawkins (HWKN), Xtrackers California Municipal Bond ETF (CA), Endologix (ELGX), Chipotle Mexican Grill (CMG), BlackRock (BLK), Aegean Marine Petroleum Network (ANW), Micron Technology (MU), Hudson Technologies (HDSN), Accenture (ACN) and AutoZone (AZO). How do I buy shares of Genocea Biosciences? Shares of GNCA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:GNCA) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genocea Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
